Allergy Therapeutics Plc
(OTC) AGYTF
Allergy Therapeutics Plc Financials at a Glance
Market Cap
$696.58M
Revenue (TTM)
$122.41M
Net Income (TTM)
$84.56M
EPS (TTM)
$-0.01
P/E Ratio
-8.46
Dividend
$0.00
Beta (Volatility)
0.37 (Low)
Dividend
$0.00
Beta (Volatility)
0.37 (Low)
Price
$0.11
Volume
20,000
Open
$0.11
Price
$0.11
Volume
20,000
Open
$0.11
Previous Close
$0.11
Daily Range
$0.11 - $0.11
52-Week Range
$0.08 - $0.11
Dividend
$0.00
Beta (Volatility)
0.37 (Low)
Price
$0.11
Volume
20,000
Open
$0.11
Previous Close
$0.11
Daily Range
$0.11 - $0.11
52-Week Range
$0.08 - $0.11
AGYTF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Allergy Therapeutics Plc
Industry
Pharmaceuticals
Sector
Health CareEmployees
612
CEO
Manuel Llobet, MBA
Website
www.allergytherapeutics.comHeadquarters
Worthing, BN14 8SA, GB
AGYTF Financials
Key Financial Metrics (TTM)
Gross Margin
41%
Operating Margin
-60%
Net Income Margin
-85%
Return on Equity
0%
Return on Capital
-89%
Return on Assets
-69%
Earnings Yield
-11.82%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$696.58M
Shares Outstanding
6.33B
Volume
20.00K
Short Interest
0.00%
Avg. Volume
1.40K
Financials (TTM)
Gross Profit
$34.50M
Operating Income
$28.16M
EBITDA
$40.40M
Operating Cash Flow
$39.42M
Capital Expenditure
$4.48M
Free Cash Flow
$43.90M
Cash & ST Invst.
$17.56M
Total Debt
$60.09M
Allergy Therapeutics Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$36.27M
+8.0%
Gross Profit
$19.32M
-5.9%
Gross Margin
53.26%
N/A
Market Cap
$696.58M
N/A
Market Cap/Employee
$1.14M
N/A
Employees
612
N/A
Net Income
$19.91M
-27.2%
EBITDA
$9.76M
-4.4%
Quarterly Fundamentals
Net Cash
$16.67M
-553.9%
Accounts Receivable
$10.98M
+10.5%
Inventory
$13.79M
+15.9%
Long Term Debt
$24.79M
+206.0%
Short Term Debt
$1.96M
+12.2%
Return on Assets
-68.96%
N/A
Return on Invested Capital
-88.54%
N/A
Free Cash Flow
$14.51M
-14.8%
Operating Cash Flow
$11.71M
-8.7%